Literature DB >> 20598978

Chronic obstructive pulmonary disease after myocardial infarction in the community.

Francesca Bursi1, Robert Vassallo, Susan A Weston, Jill M Killian, Véronique L Roger.   

Abstract

BACKGROUND: Myocardial infarction (MI) and chronic obstructive pulmonary disease (COPD) are frequent and share common risk factors. Yet, studies on MI patients reported limited and conflicting results on the prevalence of COPD, its impact on outcome, and how these may have changed over time. We examined, in a geographically defined community, the prevalence of COPD in patients with MI, its impact on mortality, and how these associations changed over time.
METHODS: Residents of Olmsted County, Minnesota, who experienced an MI meeting standardized criteria from 1979 to 2007 were included (3,438, 42% women, mean age 68 +/- 15 years). Chronic obstructive pulmonary disease was ascertained from the medical records.
RESULTS: Of 3,438 patients, 415 (12%) had COPD. During the study, COPD prevalence increased from 7% in 1979-1985 to 15% in 2000-2007 (P < .001). Survival was worse in patients with COPD than in those without COPD (5-year survival rate: 46% [95% CI 41%-52%] vs 68% [95% CI 66%-70%], respectively; P < .01). The association between COPD and death was independent of age and risk factors (adjusted hazard ratio 1.30, 95% CI 1.10-1.54, P < .01) and did not change over time.
CONCLUSIONS: In a large community of patients with MI, the prevalence of COPD increased over time and was associated with a markedly increased risk of death after MI independently of age, risk factors, and comorbidity. This underscores the importance of this condition and the need to optimize care for these high-risk patients. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20598978      PMCID: PMC2897833          DOI: 10.1016/j.ahj.2010.05.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  32 in total

Review 1.  Chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

2.  Death certificate reporting of confirmed airways obstructive disease.

Authors:  A E Camilli; D R Robbins; M D Lebowitz
Journal:  Am J Epidemiol       Date:  1991-04-15       Impact factor: 4.897

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994.

Authors:  Véronique L Roger; Steven J Jacobsen; Susan A Weston; Tauqir Y Goraya; Jill Killian; Guy S Reeder; Thomas E Kottke; Barbara P Yawn; Robert L Frye
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

6.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Authors:  Nathaniel M Hawkins; Zhen Huang; Karen S Pieper; Scott D Solomon; Lars Kober; Eric J Velazquez; Karl Swedberg; Marc A Pfeffer; John J V McMurray; Aldo P Maggioni
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

7.  Smoking and lung function in elderly men and women. The Cardiovascular Health Study.

Authors:  M W Higgins; P L Enright; R A Kronmal; M B Schenker; H Anton-Culver; M Lyles
Journal:  JAMA       Date:  1993-06-02       Impact factor: 56.272

8.  Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group.

Authors:  S Behar; A Panosh; H Reicher-Reiss; M Zion; Z Schlesinger; U Goldbourt
Journal:  Am J Med       Date:  1992-12       Impact factor: 4.965

9.  Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction.

Authors:  Erik Kjøller; Lars Køber; Kasper Iversen; Christian Torp-Pedersen
Journal:  Eur J Heart Fail       Date:  2004-01       Impact factor: 15.534

10.  Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

View more
  18 in total

1.  Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.

Authors:  Spyridon Liosis; Timm Bauer; Rudolf Schiele; Helmut Gohlke; Martin Gottwik; Hugo Katus; Georg Sabin; Ralf Zahn; Steffen Schneider; Bernhard Rauch; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2013-06-06       Impact factor: 5.460

2.  Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period.

Authors:  Tiina Mattila; Tuula Vasankari; Harri Rissanen; Paul Knekt; Pauli Puukka; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2017-07-07       Impact factor: 8.082

3.  β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.

Authors:  Pontus Andell; David Erlinge; J Gustav Smith; Johan Sundström; Bertil Lindahl; Stefan James; Sasha Koul
Journal:  J Am Heart Assoc       Date:  2015-04-08       Impact factor: 5.501

Review 4.  Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.

Authors:  Cheryl R Laratta; Stephan van Eeden
Journal:  Biomed Res Int       Date:  2014-03-02       Impact factor: 3.411

5.  Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan.

Authors:  Katsuya Onishi; Daisuke Yoshimoto; Gerry W Hagan; Paul W Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-29

6.  Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction.

Authors:  Pontus Andell; Sasha Koul; Andreas Martinsson; Johan Sundström; Tomas Jernberg; J Gustav Smith; Stefan James; Bertil Lindahl; David Erlinge
Journal:  Open Heart       Date:  2014-02-03

7.  Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease.

Authors:  Kieran J Rothnie; Liam Smeeth; Emily Herrett; Neil Pearce; Harry Hemingway; Jadwiga Wedzicha; Adam Timmis; Jennifer K Quint
Journal:  Heart       Date:  2015-03-12       Impact factor: 5.994

8.  Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.

Authors:  Pere Almagro; Anna Lapuente; Julia Pareja; Sergi Yun; Maria Estela Garcia; Ferrán Padilla; Josep L I Heredia; Alex De la Sierra; Joan B Soriano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-16

Review 9.  Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.

Authors:  Kieran J Rothnie; Ruoling Yan; Liam Smeeth; Jennifer K Quint
Journal:  BMJ Open       Date:  2015-09-11       Impact factor: 2.692

10.  Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.

Authors:  J K Quint; E Herrett; K Bhaskaran; A Timmis; H Hemingway; J A Wedzicha; L Smeeth
Journal:  BMJ       Date:  2013-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.